TP53 and lymphoma: Interestingly, a follow-up study also identified p53-independent induction of cell death following DHX9 inhibition in p53-deficient mouse lymphomas and colon cancer cells, highlighting the dependency of both p53-wildtype and p53-deficient tumors on DHX9 for survival [83,84].